Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. (nature.com)

Authors: Aronne LJ … Xavier N Journal: Nature Medicine Published: 2026-05-13 DOI: https://doi.org/10.1038/s41591-026-04386-7